Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1989 Feb;64(2):229–234. doi: 10.1136/adc.64.2.229

The captopril test: an aid to investigation of hypertension.

C E Daman Willems 1, V Shah 1, M Uchiyama 1, M J Dillon 1
PMCID: PMC1791859  PMID: 2649017

Abstract

Twenty three children aged from 5 to 16 with mild to moderate hypertension were investigated using the orally active angiotensin converting enzyme inhibitor captopril. Falls in both systolic and diastolic blood pressure after a single dose of captopril were significantly correlated with initial plasma renin activity. In addition, some information about the aetiology of hypertension was deduced from the renin response to captopril. The blood pressure response to captopril is a useful screening test for renin dependent hypertension in childhood.

Full text

PDF
229

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Case D. B., Atlas S. A., Laragh J. H. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension. Clin Sci (Lond) 1979 Dec;57 (Suppl 5):313s–316s. doi: 10.1042/cs057313s. [DOI] [PubMed] [Google Scholar]
  2. DICKINSON C. J., LAWRENCE J. R. A slowly developing pressor response to small concentrations of angiotensin. Its bearing on the pathogenesis of chronic renal hypertension. Lancet. 1963 Jun 22;1(7295):1354–1356. doi: 10.1016/s0140-6736(63)91929-9. [DOI] [PubMed] [Google Scholar]
  3. Dillon M. J. Measurement of plasma renin activity by semi-micro radioimmunoassay of generated angiotensin I. J Clin Pathol. 1975 Aug;28(8):625–630. doi: 10.1136/jcp.28.8.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dillon M. J., Ryness J. M. Plasma renin activity and aldosterone concentration in children. Br Med J. 1975 Nov 8;4(5992):316–319. doi: 10.1136/bmj.4.5992.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ferguson R. K., Turini G. A., Brunner H. R., Gavras H., McKinstry D. N. A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet. 1977 Apr 9;1(8015):775–778. doi: 10.1016/s0140-6736(77)92958-0. [DOI] [PubMed] [Google Scholar]
  6. Gavras H., Brunner H. R., Turini G. A., Kershaw G. R., Tifft C. P., Cuttelod S., Gavras I., Vukovich R. A., McKinstry D. N. Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N Engl J Med. 1978 May 4;298(18):991–995. doi: 10.1056/NEJM197805042981803. [DOI] [PubMed] [Google Scholar]
  7. Hodsman G. P., Isles C. G., Murray G. D., Usherwood T. P., Webb D. J., Robertson J. I. Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed) 1983 Mar 12;286(6368):832–834. doi: 10.1136/bmj.286.6368.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Leumann E. P. Blood pressure and hypertension in childhood and adolescence. Ergeb Inn Med Kinderheilkd. 1979;43:109–183. doi: 10.1007/978-3-642-67379-5_4. [DOI] [PubMed] [Google Scholar]
  9. Muller F. B., Sealey J. E., Case D. B., Atlas S. A., Pickering T. G., Pecker M. S., Preibisz J. J., Laragh J. H. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med. 1986 Apr;80(4):633–644. doi: 10.1016/0002-9343(86)90819-3. [DOI] [PubMed] [Google Scholar]
  10. Streeten D. H., Anderson G. H., Freiberg J. M., Dalakos T. G. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;. N Engl J Med. 1975 Mar 27;292(13):657–662. doi: 10.1056/NEJM197503272921301. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES